Serum magnesium

Biomarker1 paper1 finding

Human trial1

Interventions

1

Empagliflozin

upin humans1Very low certainty

1 study

Empagliflozin increases serum magnesium in humans (0.26 ± 0.38 mg/dL).
“Empagliflozin increased serum magnesium (mean difference = 0.26 ± 0.38 mg/dL”
Human trialtype 2 diabetes1 month
Metabolic and Lipoprotein Changes in Type 2 Diabetes Patients Treated with Empagliflozin · Biomedicines · 8 Sep 2026

Empagliflozin →

Latest

1

BiomedicinesHuman trial26 Sep

Metabolic and Lipoprotein Changes in Type 2 Diabetes Patients Treated with Empagliflozin